Akero Therapeutics is a clinical stage biopharmaceutical company focused on discovering and developing transformational treatments for patients with serious metabolic diseases.
Akero Therapeutics is a clinical stage biopharmaceutical company seeking a Director/Sr. Director - Clinical Development to contribute to the execution of the Phase 3 clinical development programme for Efruxifermin (EFX). The ideal candidate will have a medical background, experience in hepatology, and strong collaboration and communication skills.
Akero Therapeutics is a clinical stage biopharmaceutical company focused on discovering and developing transformational treatments for patients with serious metabolic diseases.
Eikon Therapeutics